Comparing Benlysta vs Mycophenolate Mofetil
| Benlysta (belimumab) | Mycophenolate mofetil |
|
|---|
| Benlysta (belimumab) | Mycophenolate mofetil |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Benlysta is an injectable non-steroid prescription medicine used with other medicines to treat systemic lupus erythematosus (SLE) and active lupus nephritis (lupus-related kidney inflammation) in... View more |
Prescription only
Prescribed for Autoimmune Hepatitis, Bullous Pemphigoid, Crohn's Disease, Cogan's Syndrome, Organ Transplant - Rejection Prophylaxis, Dermatomyositis, Evan's Syndrome, Graft Versus Host Disease, High... View more |
Related suggestions Lupus Nephritis
Popular comparisons
|
|||||||||||||||
| More about Benlysta (belimumab) | More about Mycophenolate mofetil | ||||||||||||||||
| Ratings & Reviews | |||||||||||||||||
|
Benlysta has an average rating of 7.9 out of 10 from a total of 63 ratings on Drugs.com. 67% of reviewers reported a positive effect, while 8% reported a negative effect. |
Mycophenolate mofetil has an average rating of 8.0 out of 10 from a total of 60 ratings on Drugs.com. 71% of reviewers reported a positive effect, while 11% reported a negative effect. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||||||||||
View all Benlysta side effects |
View all Mycophenolate mofetil side effects |
||||||||||||||||
| Drug Class | |||||||||||||||||
| Generic Availability | |||||||||||||||||
|
N/A |
Lower cost generic |
||||||||||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Benlysta prices |
View all Mycophenolate mofetil prices |
||||||||||||||||
| Dosage Forms | |||||||||||||||||
|
|
||||||||||||||||
| Brand Names | |||||||||||||||||
|
N/A |
CellCept, Myhibbin | ||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||||||||||
|
465.6 hours |
18 hours |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | |||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | |||||||||||||||||
|
A total of 239 drugs are known to interact with Benlysta:
|
A total of 340 drugs are known to interact with Mycophenolate mofetil:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
| Disease Interactions | |||||||||||||||||
| First Approval Date | |||||||||||||||||
|
March 09, 2011 |
May 03, 1995 |
||||||||||||||||
| WADA Class View classifications | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| More Information | |||||||||||||||||
| Patient Resources | |||||||||||||||||
| Professional Resources | |||||||||||||||||
| Related Treatment Guide | |||||||||||||||||
|
|||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.